Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma

BACKGROUND: Ritonavir was recently combined with nirmatrelvir in a new approved co-packaged medication form for the treatment of COVID-19. Quantitative analysis based on fluorescence spectroscopy measurement was extensively used for sensitive determination of compounds exhibited unique fluorescence...

Descripción completa

Detalles Bibliográficos
Autores principales: Imam, Mohamed S., Abdelazim, Ahmed H., Ramzy, Sherif, Almrasy, Ahmed A., Gamal, Mohammed, Batubara, Afnan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514966/
https://www.ncbi.nlm.nih.gov/pubmed/37735663
http://dx.doi.org/10.1186/s13065-023-01030-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514966/
https://www.ncbi.nlm.nih.gov/pubmed/37735663
http://dx.doi.org/10.1186/s13065-023-01030-0

Ejemplares similares